PDGFRB and central nervous system cancer: In approximately 30% of human gliomas, expression of genes associated with PDGFR signaling and genes involved in oligodendrocyte development (OLIG2, NKX2-2, and PDGF), are observed and are thought to be hallmarks of the PN signature in GBM [9].